ANAVEX LIFE SCIENCES CORP. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q4 2012 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Anavex Life Sciences Corp. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q4 2012 to Q3 2024.
  • Anavex Life Sciences Corp. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 83.5M shares, a 4.61% increase year-over-year.
  • Anavex Life Sciences Corp. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 83.5M shares, a 4.61% increase from 2023.
  • Anavex Life Sciences Corp. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 79.8M shares, a 3.74% increase from 2022.
  • Anavex Life Sciences Corp. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 76.9M shares, a 10.2% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 83.5M +3.68M +4.61% Jul 1, 2024 Sep 30, 2024 10-K 2024-12-23
Q2 2024 84.5M +3.66M +4.53% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 82.5M +4.16M +5.31% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 82.1M +4.1M +5.26% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-07
Q3 2023 79.8M Jul 1, 2023 Sep 30, 2023 10-K 2024-12-23
Q2 2023 80.9M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 78.3M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 78M Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-07
Q1 2017 41.2M +5.94M +16.9% Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-10
Q4 2016 38.4M +4.42M +13% Oct 1, 2016 Dec 31, 2016 10-Q 2017-02-07
Q3 2016 35.2M +16.6M +89.2% Jul 1, 2016 Sep 30, 2016 10-K 2016-12-14
Q2 2016 35.7M +16.6M +87% Apr 1, 2016 Jun 30, 2016 10-Q 2016-08-11
Q1 2016 35.2M +20.9M +146% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 34M +21.1M +163% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-07
Q3 2015 18.6M +8.78M +89.6% Jul 1, 2015 Sep 30, 2015 10-K 2016-12-14
Q2 2015 19.1M -20.2M -51.4% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 14.3M -23.6M -62.2% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-11
Q4 2014 12.9M -24.6M -65.6% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-08
Q3 2014 9.8M -22.1M -69.3% Jul 1, 2014 Sep 30, 2014 10-K 2016-12-14
Q2 2014 39.3M +9.02M +29.8% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 37.9M +7.64M +25.3% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 37.5M +7.24M +24% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-17
Q3 2013 31.9M Jul 1, 2013 Sep 30, 2013 10-K 2014-12-29
Q2 2013 30.2M Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-13
Q1 2013 30.2M Jan 1, 2013 Mar 31, 2013 10-Q/A 2014-05-30
Q4 2012 30.2M Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.